866-997-4948(US-Canada Toll Free)

Bordetella Pertussis Infections Global Clinical Trials Review, H2, 2014

Published By :

GlobalData

Published Date : Nov 2014

Category :

Clinical Trials

No. of Pages : 94 Pages


GlobalData's clinical trial report, Bordetella Pertussis Infections Global Clinical Trials Review, H2, 2014" provides data on the Bordetella Pertussis Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bordetella Pertussis Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bordetella Pertussis Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents 2
List of Tables 4
List of Figures 5

Introduction 6
Bordetella Pertussis Infections 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bordetella Pertussis Infections to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bordetella Pertussis Infections to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Bordetella Pertussis Infections 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Bordetella Pertussis Infections Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Sanofi 39
Clinical Trial Overview of Sanofi 39
Merck & Co., Inc. 45
Clinical Trial Overview of Merck & Co., Inc. 45
Panacea Biotec Limited 47
Clinical Trial Overview of Panacea Biotec Limited 47
PT Bio Farma 48
Clinical Trial Overview of PT Bio Farma 48
LG Life Sciences, Ltd. 49
Clinical Trial Overview of LG Life Sciences, Ltd. 49
Serum Institute of India Limited 50
Clinical Trial Overview of Serum Institute of India Limited 50
Novartis AG 51
Clinical Trial Overview of Novartis AG 51
Daiichi Sankyo Company, Limited 52
Clinical Trial Overview of Daiichi Sankyo Company, Limited 52
Crucell N.V. 53
Clinical Trial Overview of Crucell N.V. 53
Clinical Trial Overview of Top Institutes / Government 54
The National Institute of Allergy and Infectious Diseases 54
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 54
National Institute for Public Health and the Environment 55
Clinical Trial Overview of National Institute for Public Health and the Environment 55
Dalhousie University 56
Clinical Trial Overview of Dalhousie University 56
Statens Serum Institut 57
Clinical Trial Overview of Statens Serum Institut 57
Health Protection Agency 58
Clinical Trial Overview of Health Protection Agency 58
Swedish Institute for Communicable Disease Control 59
Clinical Trial Overview of Swedish Institute for Communicable Disease Control 59
Center for Genetic Engineering and Biotechnology 60
Clinical Trial Overview of Center for Genetic Engineering and Biotechnology 60
Bio-Manguinhos 61
Clinical Trial Overview of Bio-Manguinhos 61
Yale University 62
Clinical Trial Overview of Yale University 62
Memorial Sloan Kettering Cancer Center 63
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 63
Five Key Clinical Profiles 64

Appendix 92
Abbreviations 92
Definitions 92
Research Methodology 93
Secondary Research 93
About GlobalData 94
Contact Us 94
Disclaimer 94
Source 94

List of Table


Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials by Region, 2014* 7
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bordetella Pertussis Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Bordetella Pertussis Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Bordetella Pertussis Infections Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Bordetella Pertussis Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Bordetella Pertussis Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Bordetella Pertussis Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Bordetella Pertussis Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bordetella Pertussis Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bordetella Pertussis Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Bordetella Pertussis Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bordetella Pertussis Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bordetella Pertussis Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Bordetella Pertussis Infections Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Bordetella Pertussis Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 33
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 39
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 45
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Panacea Biotec Limited, 2014* 47
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by PT Bio Farma, 2014* 48
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by LG Life Sciences, Ltd., 2014* 49
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Serum Institute of India Limited, 2014* 50
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 51
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 52
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Crucell N.V., 2014* 53
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 54
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute for Public Health and the Environment, 2014* 55
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Dalhousie University, 2014* 56
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Statens Serum Institut, 2014* 57
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Health Protection Agency, 2014* 58
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Swedish Institute for Communicable Disease Control, 2014* 59
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Center for Genetic Engineering and Biotechnology, 2014* 60
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio-Manguinhos, 2014* 61
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014* 62
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 63

List of Chart


Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bordetella Pertussis Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Bordetella Pertussis Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Bordetella Pertussis Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Bordetella Pertussis Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Bordetella Pertussis Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Bordetella Pertussis Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Bordetella Pertussis Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bordetella Pertussis Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bordetella Pertussis Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Bordetella Pertussis Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bordetella Pertussis Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Bordetella Pertussis Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 93

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *